Comparison of risk classification between EndoPredict and MammaPrint in ER-positive/HER2-negative primary invasive breast cancer

@inproceedings{PelezGarca2017ComparisonOR,
  title={Comparison of risk classification between EndoPredict and MammaPrint in ER-positive/HER2-negative primary invasive breast cancer},
  author={Alberto Pel{\'a}ez-Garc{\'i}a and Laura Y{\'e}benes and Alberto Berj{\'o}n and Antonia Angulo and Pilar M. Zamora and Jos{\'e} Ignacio S{\'a}nchez-M{\'e}ndez and Enrique Espinosa and A. Carrillo Redondo and Victoria Heredia-Soto and Marta Mendiola and Jaime Feli{\'u} and David Hardisson},
  booktitle={PloS one},
  year={2017}
}
PURPOSE To compare the concordance in risk classification between the EndoPredict and the MammaPrint scores obtained for the same cancer samples on 40 estrogen-receptor positive/HER2-negative breast carcinomas. METHODS Formalin-fixed, paraffin-embedded invasive breast carcinoma tissues that were previously analyzed with MammaPrint as part of routine care of the patients, and were classified as high-risk (20 patients) and low-risk (20 patients), were selected to be analyzed by the EndoPredict… CONTINUE READING

From This Paper

Figures, tables, results, connections, and topics extracted from this paper.
0 Extracted Citations
24 Extracted References
Similar Papers

Referenced Papers

Publications referenced by this paper.
Showing 1-10 of 24 references

Similar Papers

Loading similar papers…